|Articles|April 17, 2007
Intermediate AMD: managing the disease before CNV develops
Patient education is a critical factor in the early diagnosis of intermediate age-related macular degeneration (AMD), said Rubens Belfort Jr., MD, PhD, MBA, Vision Institute, Federal University of São Paulo, Brazil. Dr. Belfort offered his approach to managing intermediate AMD by focusing on preventing progression to choroidal neovascularization (CNV) and geographic atrophy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5














































.png)


